Trademarkia Logo

United Kingdom

£
Trademark Search
VOYAGER

View On IPO.GOV.UK

Registered

on 8 Feb 2022

Last Applicant/ Owned by

Voyager Therapeutics, Inc.

75 Sidney Street, Cambridge

Massachusetts, , 02139

Serial Number

UK00003752385 filed on 8th Feb 2022

Registration Number

UK00003752385 registered on
15th Jul 2022

Correspondent Information

Laytons LLP

Yarnwicke, 1st Floor, 119 - 121 Cannon Street

London,

EC4N 5AT

VOYAGER

biological preparations for gene therapy; adeno-associated virus (aav) gene therapy; biological preparations for treatment of neurological diseases an Read More

Classification Information

Class [5]
Pharmaceutical Products

Biological preparations for gene therapy; adeno-associated virus (AAV) gene therapy; Biological preparations for treatment of neurological diseases and disorders; gene therapy preparations for treatment of disease, namely, treatment of disease, namely, neurological diseases; treatments for neurological diseases via gene replacement, gene knockdown, or vectorized antibodies; gene therapy preparations for neurological diseases; polypeptides for gene therapy; Drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals and biotherapeutics; Drug delivery agents consisting of capsids that facilitate delivery of a wide range of pharmaceuticals and biotherapeutics.

Class [42]
Computer & Software Services & Scientific Services

Pharmaceutical research and development in the field of gene therapy; Pharmaceutical research and development for the treatment of neurological diseases and disorders; scientific research in the field of gene therapy; pharmaceutical research services; research and development of pharmaceutical preparations for gene therapy; research and development of pharmaceutical preparations for neurological diseases; biotechnology research services; research and development of platform technologies for genetic delivery of therapies and pharmaceuticals; research, development, and collaboration services in the field of platforms technologies for genetic delivery of therapies and pharmaceuticals; research and development in the pharmaceutical and biotechnology fields; research and development regarding the use of RNA-based functional screening platforms to discover, research and develop novel capsids for genetic deliver of therapies and pharmaceuticals; research and development regarding the identification and targeting of specific cells and tissues for gene therapy delivery.

Class [44]
Medical, Beauty & Agricultural Services

Medical services provided for clinical trials; Providing patient care for clinical trials; Providing medical and scientific research information in the field of clinical trials and gene therapy; Providing a website featuring medical information and medical research.

Mark Details

Serial Number

UK00003752385

Mark Type

Figurative

Kind of mark

Individual